Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹1,476.05
Market cap: ₹2,109 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 48.1×Sector 47.3×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 5 Financial Results 4 Other Announcement 3 Earnings Call 3 Results Update 2 Bonus Issue 2 Annual General Meeting 2 Acquisition 2 Product Launch 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 14:48 IST BSE

Debt & Borrowing

Fredun Pharmaceuticals Debt & Borrowing: ₹216.4 Cr

Fredun Pharmaceuticals Ltd (BSE: 539730) confirmed it does not qualify as a 'Large Corporate' under SEBI debt-raising norms for the 2026 financial year. The company reported outstanding borrowings of ₹216.43 Crore as of March 31. This routine regulatory disclosure provides transparency regarding the company's borrowing framework and debt market compliance status.

Value: ₹216.4 Cr

Read the filing ↗